drugset / Trial / NCT00003548

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

NCT00003548 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of aminocamptothecin in treating patients with advanced cancer of the peritoneal cavity.

Timeline

Start
1998-08
Primary completion
2001-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject 9-aminocamptothecin Small molecule — Other

Indications